In a story Oct. 9 about an experimental gene therapy for blindness, The Associated Press erroneously reported the deadline for a decision by the U.S. Food and Drug Administration. The date is Jan. 12, not Jan. 18.
A corrected version of the story is below:
Seeing hope: FDA panel considers gene therapy for blindness
Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at restoring vision for some people with hereditary blindness
By MARILYNN MARCHIONE
AP Chief Medical Writer
A girl saw her mother's face for the first time. A boy tore through the aisles of Target,...